申请人:Pfizer Inc.
公开号:US05677324A1
公开(公告)日:1997-10-14
The present invention relates to compounds of formula (I) and the pharmaceutically acceptable salts thereof, wherein the dashed line represents an optional covalent bond; X is O, NH, S or a direct link; R.sup.3 is hydroxy when the dashed line does not represent a covalent bond and R.sup.3 is absent when the dashed line represents a covalent bond; R.sup.4 is (a), when X is O, a group of formula (i), (b), when X is O, NH or S, optionally substituted hydroxyphenyl, (c) an optionally substituted 4- to 7-membered heterocyclic ring, or (d), when X is NH, a group of formula (ii). The compounds are useful for the treatment of disease associated with the altered tone or motility of smooth muscle. ##STR1##
本发明涉及式(I)的化合物及其药学上可接受的盐,其中虚线代表可选的共价键;X为O、NH、S或直接连接;当虚线不代表共价键时,R.sup.3为羟基,当虚线代表共价键时,R.sup.3不存在;当X为O时,R.sup.4为(a),为式(i)的基团,当X为O、NH或S时,为可选取代的羟基苯基(b),为可选取代的4-至7-成员杂环环(c),或当X为NH时,为式(ii)的基团(d)。这些化合物对于治疗与平滑肌张力或运动异常相关的疾病是有用的。